Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refrac
- This topic has 0 replies, 1 voice, and was last updated 2 years, 7 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma
https://pubmed.ncbi.nlm.nih.gov/34480077/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.